| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis | |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis | |
| | CFTR, LOC111674475 (S549R) | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | CFTR, LOC111674475 (S549N) | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | CFTR, LOC111674475 (S549R) | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | CFTR, LOC111674475 (G551S) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy +1 more | GPathogenic; drug response |
| | CFTR, LOC111674475 (G551D) | Single nucleotide variant (missense variant) | Cystic fibrosis | |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | LOC111674472, CFTR (F1052V) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | CFTR, LOC111674472 (K1060T) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | CFTR, LOC111674472 (A1067T) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | CFTR, LOC111674472 (R1070W) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | CFTR, LOC111674472 (R1070Q) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | LOC111674472, CFTR (F1074L) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy | |
| | | Single nucleotide variant (missense variant) | Cystic fibrosis +1 more | GPathogenic; drug response |